Growth hormones : synthesis, regulation & health implications / edited by Anne Andersdtr, Jon Anderssen.
Material type:
TextSeries: Endocrinology research and clinical developments | Metabolic diseases--laboratory and clinical research seriesPublisher: New York : Nova Science Publishers, Inc., ©2012Description: 1 online resource (x, 170 pages) : illustrationsContent type: - text
- computer
- online resource
- 9781619426894
- 1619426897
- 571.8374 23
- QP572.P4 G76 2012eb
| Item type | Home library | Collection | Call number | Materials specified | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|---|
Electronic-Books
|
OPJGU Sonepat- Campus | E-Books EBSCO | Available |
Includes bibliographical references and index.
"Nova biomedical."
Print version record.
GROWTH HORMONES: SYNTHESIS, REGULATION AND HEALTH IMPLICATIONS; GROWTH HORMONES: SYNTHESIS, REGULATION AND HEALTH IMPLICATIONS; LIBRARY OF CONGRESS CATALOGING-IN-PUBLICATION DATA; CONTENTS; PREFACE; Chapter 1: BIOTECH PLATFORM FOR DISCOVERY AND ASSESSMENT OF GROWTH HORMONES; 1. MODERN BIOTECHNOLOGY AND THE PRODUCTION OF PROTEIN HORMONES; 2. THE GROWTH HORMONE (GH) FAMILY; 3. GROWTH HORMONES OF ANIMAL ORIGIN; 4. BIOLOGICAL POTENTIAL OF GHS; 5. EXPRESSION SYSTEMS FOR GROWTH HORMONES; 6. TECHNOLOGICAL PLATFORM FOR CLONING GHS; 7. TECHNOLOGICAL PLATFORM FOR PRODUCING RECOMBINANT GHS.
8. CONSTRUCTION OF GHS PRODUCING PICHIA PASTORIS STRAINS9. PRODUCTION AND ANALYSIS OF RECOMBINANT HORMONES IN ERLENMEYER FLASK; 10. PRODUCTION SCALING IN THE BIOREACTOR; 11. SEMIPURIFICATION OF RECOMBINANT HORMONES; 12. TESTING THE BIOLOGICAL ACTIVITY OF RECOMBINANT HORMONES; 13. CONTRIBUTIONS; 14. PERSPECTIVES; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: THEORETICAL APPROACHESTO GROWTH HORMONE SIGNALING; Abstract; 1. Introduction; 2. Mathematical Modeling of Ligand-Receptor Systems; 3. 1:1 Interaction Model; 4. 1:2 Symmetric Interaction Model; 5. 1:2 Symmetric and Sequential Interaction Model.
6. 1:2 Asymmetric and Sequential Interaction Model7. Self-Antagonist Effect; 8. Enhanced Efficiency of GH Ligand Homodimers; 9. Receptor Monomer Versus Receptor Dimer Hypotheses; 10. Conclusion; 11. Acknowledgments; References; Chapter 3: EFFECT OF GROWTH HORMONE ON LIPID METABOLISM -- BASIC AND CLINICAL ASPECTS; ABSTRACT; ABBREVIATIONS; 1. INTRODUCTION; 2. GROWTH HORMONE: CHEMISTRY, GENE EXPRESSION AND SECRETION CONTROL; 3. GROWTH HORMONE RECEPTOR AND SIGNALING CASCADE; 4. EFFECTS OF GROWTH HORMONE ON LIPID METABOLISM IN THE ADIPOSE TISSUE, LIVER AND SKELETAL MUSCLE.
5. STUDIES OF GROWTH HORMONE SECRETION AND ACTIONS IN HUMANS6. OBESITY, METABOLIC SYNDROME AND GROWTH HORMONE; 7. GROWTH HORMONE DEFICIENCY AND VISCERAL (TRUNCAL) OBESITY; 8. GROWTH HORMONE TREATMENT AND PERSPECTIVES; REFERENCES; Chapter 4: THE HUMAN GROWTH HORMONE: SYNTHESIS, REGULATION AND HEALTH IMPLICATIONS; ABSTRACT; I. INTRODUCTION; II. HGH SYNTHESIS AND REGULATION; III. BIOLOGICAL RELEVANCE AND IMPACT ON HEALTH; CONCLUSION; REFERENCES; Chapter 5: CIRCULATION CONCENTRATION OF ESTRADIOL, GROWTH HORMONE, INSULIN LIKE GROWTH FACTOR AFTER FOLLICLE ASPIRATION IN CATTLE; ABSTRACT.
1. INTRODUCTION2. MATERIALS AND METHODS; 3. RESULT; 4. DISCUSSION; REFERENCES; Chapter 6: STABILITY STUDY OF SOMATROPIN BY CAPILLARY ZONE ELECTROPHORESIS; ABSTRACT; INTRODUCTION; EXPERIMENTAL; RESULTS AND DISCUSSION; CONCLUSION; REFERENCES; Chapter 7: CARDIAC EFFECTS OF GROWTH HORMONE TREATMENT IN PEDIATRIC POPULATIONS; INTRODUCTION; BACKGROUND; GROWTH HORMONE THERAPY IN THE CARDIAC SETTING; ISOLATED GH DEFICIENCY; TURNER SYNDROME; NOONAN SYNDROME; PRADER-WILLI SYNDROME; SMALL FOR GESTATIONAL AGE (SGA); INDUCED GH DEFICIENCY; CONCLUSION; REFERENCES.
Chapter 8: RECOMBINANT HUMAN GROWTH HORMONE TREATMENT IN PATIENTS WITH GROWTH DEFICIENCY AND CROHN'S DISEASE -- NEW PERSPECTIVES.
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide
There are no comments on this title.